Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
In recent years, there has been an increase in deaths due to infectious diseases, most notably in the context of viral respiratory pathogens. Consequently, the focus has shifted in the search for new therapies, with attention being drawn to the use of nanoparticles in mRNA vaccines for targeted deli...
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, Ali Kamedi, Andrew O’ Neill, Ronan MacLoughlin, Mohammad Doroudian |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/15/4/1127 |
Similar Items
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022-02-01)
by: Sean C. Semple, et al.
Published: (2022-02-01)
In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA
by: Ayoub Medjmedj, et al.
Published: (2022-07-01)
by: Ayoub Medjmedj, et al.
Published: (2022-07-01)
Development and application of an uncapped mRNA platform
by: Xiaodi Zheng, et al.
Published: (2025-12-01)
by: Xiaodi Zheng, et al.
Published: (2025-12-01)
Microfluidic and Turbulent Mixing for mRNA LNP Vaccines
by: Patrick L. Ahl
Published: (2025-09-01)
by: Patrick L. Ahl
Published: (2025-09-01)
Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability
by: Mariko Kamiya, et al.
Published: (2022-10-01)
by: Mariko Kamiya, et al.
Published: (2022-10-01)
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
by: Zhongyan Wu, et al.
Published: (2024-08-01)
by: Zhongyan Wu, et al.
Published: (2024-08-01)
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosisResearch in context
by: Hannah Lukeman, et al.
Published: (2025-03-01)
by: Hannah Lukeman, et al.
Published: (2025-03-01)
Impact of cell line and reporter gene selection on in-vitro transfection evaluation of mRNA lipid nanoparticles
by: Zixuan Zhen, et al.
Published: (2025-10-01)
by: Zixuan Zhen, et al.
Published: (2025-10-01)
Applications of mRNA Delivery in Cancer Immunotherapy
by: Pan X, et al.
Published: (2025-03-01)
by: Pan X, et al.
Published: (2025-03-01)
Development and efficacy of a novel mRNA cocktail for the delivery of African swine fever virus antigens and induction of immune responses
by: Xing Hu, et al.
Published: (2025-06-01)
by: Xing Hu, et al.
Published: (2025-06-01)
Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
by: Magdalena M. Żak, et al.
Published: (2021-10-01)
by: Magdalena M. Żak, et al.
Published: (2021-10-01)
Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe
by: Brian K. Meyer, et al.
Published: (2024-01-01)
by: Brian K. Meyer, et al.
Published: (2024-01-01)
Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice
by: Loukia Touramanidou, et al.
Published: (2024-11-01)
by: Loukia Touramanidou, et al.
Published: (2024-11-01)
Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines
by: Nisarg Patel, et al.
Published: (2023-07-01)
by: Nisarg Patel, et al.
Published: (2023-07-01)
Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques – an evaluation of particle properties and efficiency
by: David C. Jürgens, et al.
Published: (2023-07-01)
by: David C. Jürgens, et al.
Published: (2023-07-01)
Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics
by: Kenji Miyazawa, et al.
Published: (2024-01-01)
by: Kenji Miyazawa, et al.
Published: (2024-01-01)
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response
by: Liat Bar-On, et al.
Published: (2025-10-01)
by: Liat Bar-On, et al.
Published: (2025-10-01)
Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
by: Xuan Du, et al.
Published: (2023-09-01)
by: Xuan Du, et al.
Published: (2023-09-01)
Th2 Suppression Through Antigen Liver Expression Using mRNA-LNP Technology
by: Kazunori Arai, et al.
Published: (2025-09-01)
by: Kazunori Arai, et al.
Published: (2025-09-01)
Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions
by: Muhammad Nawaz, et al.
Published: (2023-04-01)
by: Muhammad Nawaz, et al.
Published: (2023-04-01)
In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery
by: Tristan Henser‐Brownhill, et al.
Published: (2024-08-01)
by: Tristan Henser‐Brownhill, et al.
Published: (2024-08-01)
Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety
by: Irena Vlatkovic
Published: (2021-05-01)
by: Irena Vlatkovic
Published: (2021-05-01)
Identification of film-based formulations that move mRNA lipid nanoparticles out of the freezer
by: Trang Nguyen Kieu Doan, et al.
Published: (2024-06-01)
by: Trang Nguyen Kieu Doan, et al.
Published: (2024-06-01)
Impact of Extended Dosing Intervals and Ipsilateral Versus Contralateral Boosting on mRNA Vaccine Immunogenicity in Mice
by: Bin Lu, et al.
Published: (2025-03-01)
by: Bin Lu, et al.
Published: (2025-03-01)
Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice
by: Tiffany Smith, et al.
Published: (2025-08-01)
by: Tiffany Smith, et al.
Published: (2025-08-01)
Unique Features and Collateral Immune Effects of mRNA-LNP COVID-19 Vaccines: Plausible Mechanisms of Adverse Events and Complications
by: János Szebeni
Published: (2025-10-01)
by: János Szebeni
Published: (2025-10-01)
Development of a Cationic Polymeric Micellar Structure with Endosomal Escape Capability Enables Enhanced Intramuscular Transfection of mRNA-LNPs
by: Siyuan Deng, et al.
Published: (2024-12-01)
by: Siyuan Deng, et al.
Published: (2024-12-01)
A review of technological developments in lipid nanoparticle application for mRNA vaccination
by: Tzu-Fu Yeh, et al.
Published: (2023-08-01)
by: Tzu-Fu Yeh, et al.
Published: (2023-08-01)
Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers
by: Bettina Dietmair, et al.
Published: (2025-06-01)
by: Bettina Dietmair, et al.
Published: (2025-06-01)
mRNA-LNP Vaccines Targeting SmpA-PLD and OmpK-Omp22 Induce Protective Immunity Against <i>Acinetobacter baumannii</i>
by: Cong Liu, et al.
Published: (2025-07-01)
by: Cong Liu, et al.
Published: (2025-07-01)
Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: A systematic review
by: Miao Zhang, et al.
Published: (2025-09-01)
by: Miao Zhang, et al.
Published: (2025-09-01)
Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia
by: Mehrnoosh Rafiei, et al.
Published: (2025-12-01)
by: Mehrnoosh Rafiei, et al.
Published: (2025-12-01)
Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines
by: Bin Zhang, et al.
Published: (2024-01-01)
by: Bin Zhang, et al.
Published: (2024-01-01)
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
by: Zoltán Kis
Published: (2022-02-01)
by: Zoltán Kis
Published: (2022-02-01)
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination
by: Chau Thuy Tien Le, et al.
Published: (2025-05-01)
by: Chau Thuy Tien Le, et al.
Published: (2025-05-01)
Novel Efficient Lipid-Based Delivery Systems Enable a Delayed Uptake and Sustained Expression of mRNA in Human Cells and Mouse Tissues
by: Artem G. Fedorovskiy, et al.
Published: (2024-05-01)
by: Artem G. Fedorovskiy, et al.
Published: (2024-05-01)
Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting
by: Vijay Gyanani, et al.
Published: (2023-04-01)
by: Vijay Gyanani, et al.
Published: (2023-04-01)
Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges
by: Janos Szebeni
Published: (2025-03-01)
by: Janos Szebeni
Published: (2025-03-01)
α-Lactalbumin mRNA-LNP Evokes an Anti-Tumor Effect Combined with Surgery in Triple-Negative Breast Cancer
by: Yun-Ru He, et al.
Published: (2024-07-01)
by: Yun-Ru He, et al.
Published: (2024-07-01)
Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque
by: Alireza Naderi Sohi, et al.
Published: (2021-09-01)
by: Alireza Naderi Sohi, et al.
Published: (2021-09-01)
Similar Items
-
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022-02-01) -
In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA
by: Ayoub Medjmedj, et al.
Published: (2022-07-01) -
Development and application of an uncapped mRNA platform
by: Xiaodi Zheng, et al.
Published: (2025-12-01) -
Microfluidic and Turbulent Mixing for mRNA LNP Vaccines
by: Patrick L. Ahl
Published: (2025-09-01) -
Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability
by: Mariko Kamiya, et al.
Published: (2022-10-01)
